Stock analysts at Zacks Research upped their Q1 2026 earnings estimates for shares of UnitedHealth Group in a research report ...

Representative Jefferson Shreve (R-Indiana) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on March 09th, the Representative disclosed that they had sold ...

The Centers for Medicare & Medicaid Services (CMS) wiped away the agency’s stated intentions for the future of Medicare ...

Terminally ill patients left Medicare Advantage for traditional Medicare at double the rate of other enrollees from 2016 to ...

The lawsuit, filed in a Maryland state court in late February, alleges that the UnitedHealth Group subsidiary's cybersecurity standards were insufficient to prevent the attack. The Russian ransomware ...

New York state sued Allstate on Monday, accusing the insurer of failing to report a data breach that exposed drivers' license ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

The continuing circus in Washington has pushed the Department of Justice’s civil fraud investigation of UnitedHealth’s ...

We recently published a list of 10 Most Undervalued High Quality Stocks to Buy According to Analysts. In this article, we are ...

Miami-Dade County Public Schools is now offering a district-wide telehealth service. It’s available to every K-through-12 ...

Robert F. Kennedy Jr. -- head of Health and Human Services -- says U.S. has one of the worst health comes despite spending ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.